Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner

@article{Sawa1998AlternativelySF,
  title={Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner},
  author={Hiroki Sawa and Teruyo Arato Ohshima and Hiroyuki Ukita and Hiromi Murakami and Yukie Chiba and Hajime Kamada and Mitsuhiro Hara and Isamu Saito},
  journal={Oncogene},
  year={1998},
  volume={16},
  pages={1701-1712}
}
Alternative splicing of cyclin D1 gene mRNA has recently been demonstrated. The novel transcript shows no splicing at the downstream exon 4 boundary and encodes a protein with an altered carboxyl-terminal domain that is a cyclin D1 variant; exon 5 is not included in the coding sequence which terminates downstream of exon 4. We here produced cells that exogenously express each form of cyclin D1 and analysed their cell cycle regulation. We found that (1) alternative splicing forms of cyclin D1… 
Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration*
TLDR
It is argued that alternate splicing is an important determinant of the function of cyclin D1 in cellular migration.
Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists.
TLDR
Combined, these studies indicate that the cyclin D1b protein is aberrantly regulated and could contribute to therapeutic failure in the context of ER-positive breast cancer.
D-Type Cyclins and Gene Transcription
TLDR
Findings are consistent with the evolving realization that the D-type cyclins play an important biological role in governing gene transcription.
Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
The cyclin D1b oncogene arises from alternative splicing of the CCND1 transcript, and harbors markedly enhanced oncogenic functions not shared by full-length cyclin D1 (cyclin D1a). Recent studies
D-type Cyclins and Cancer
TLDR
The genes encoding D-type cyclins and their dependent kinases, CDK4 and CDK6, are proto-oncogenes implicated in many forms of cancer and can restrain cancer development and progression.
Minireview: Cyclin D1: normal and abnormal functions.
TLDR
Accumulating evidence suggests that in addition to its original description as a CDK-dependent regulator of the cell cycle, cyclin D1 also conveys cell cycle orCDK-independent functions.
Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis
TLDR
It is emphasized that cyclin D1 can have diverse effects on cells depending on its level of expression, the specific cell type, the cell context and other factors, and possible mechanisms by which cyclinD1 exerts these diverse effects are discussed.
Induced expression of human CCND1 alternative transcripts in mouse Cyl‐1 knockout fibroblasts highlights functional differences
TLDR
The data supports the emerging view that CCND1 alternate transcripts encode proteins with differing independent biological functions and suggests that CC ND1tra encodes a protein involved in regulating mitogen responsive, anchorage‐dependent G1 progression, whereasCCND1trb modulates the ability of the cell to grow in an anchorage-independent manner.
Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer
TLDR
It is revealed that cyclin D1b is specifically elevated in prostate tumorigenesis, and the A870 allele predisposes for transcript-b production in a context-specific manner, which has major implications for the analyses of D-cyclin function in the prostate.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 15 REFERENCES
Growth Factors, Differentiation Factors, and Cytokines
TLDR
The major aspects of recent research and development are discussed, providing an important update in this pioneering field.
"J."
however (for it was the literal soul of the life of the Redeemer, John xv. io), is the peculiar token of fellowship with the Redeemer. That love to God (what is meant here is not God’s love to men)
FEBS
  • Letter, 385, 143 ± 148.
  • 1996
Expl
  • Cell Res., 217, 205 ± 216.
  • 1995
Proc
  • Natl. Acad. Sci. USA, 88, 9639 ± 9642.
  • 1991
Biochem
  • Biophys. Res. Commun., 217, 195 ± 202.
  • 1995
Biochem
  • Biophys. Res. Commun., 217, 1169 ± 1176.
  • 1995
Mol
  • Cell. Biol., 15, 2612 ± 2624. Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta
  • 1995
Mol
  • Cell. Biol., 15, 2554 ± 2560.
  • 1995
Mol
  • Cell. Biol., 14, 7265 ± 7275. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E
  • 1994
...
1
2
...